Literature DB >> 6856762

Dose-rate effects in mammalian cells. IV. Repairable and nonrepairable damage in noncycling C3H 10T 1/2 cells.

R L Wells, J S Bedford.   

Abstract

Repairable and nonrepairable components of gamma-ray damage leading to cell reproductive death were determined by measuring the range over which dose rate influenced the response of non-cycling C3H 10T 1/2 mouse cells. Cell proliferation and cell cycle redistribution were eliminated as factors influencing the dose-rate effect in the system by irradiating confluent monolayers of contact inhibited cells. The radiosensitivity of the cells did not change, and no selective loss of damaged cells occurred over the extended treatment times. A pronounced dose-rate effect was observed over the range between 55.6 and 0.29 Gy/hr, but a limit to the repair-dependent dose-rate effect was reached at 0.29 Gy/hr since no further reduction in effect per unit dose was observed when the dose rate was reduced to 0.17 or 0.06 Gy/hr. The survival curves, which were simple exponential functions of dose at dose rates of 0.29 Gy/hr and below, have a common Do of 7.32 Gy and represent an accurate measurement of the nonrepairable component of damage. Log-phase cultures showed remarkably different responses over the range of dose rates, due in large part to cell cycle redistribution and in some cases, cell proliferation during exposures. The results of these studies were compared with time-dose relationships used in clinical brachy-therapy and agree remarkably well with corrections in total dose suggested by R. Paterson [Br. J. Radiol. 25, 505-516 (1952)] and A.E.S. Green [cited in F. Ellis, Curr. Top. Radiat. Res. Q. 4, 357-397 (1968)] when the standard treatment time is changed. Comparison of our data with in vivo isoeffect curves of total dose vs dose per fraction for "early" and "late" tissue responses indicate that cell cycle redistribution should not be ignored as a factor influencing time-dose relationships in radiotherapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6856762

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  8 in total

1.  Comparison of six different models describing survival of mammalian cells after irradiation.

Authors:  W Sontag
Journal:  Radiat Environ Biophys       Date:  1990       Impact factor: 1.925

2.  Development and characterization of a novel variable low dose-rate irradiator for in vivo mouse studies.

Authors:  Werner Olipitz; Sheena Hembrador; Matthew Davidson; Jacquelyn C Yanch; Bevin P Engelward
Journal:  Health Phys       Date:  2010-05       Impact factor: 1.316

Review 3.  Role of High-Linear Energy Transfer Radiobiology in Space Radiation Exposure Risks.

Authors:  Akihisa Takahashi; Hiroko Ikeda; Yukari Yoshida
Journal:  Int J Part Ther       Date:  2018-09-21

4.  Response to continuous irradiation (CI) in relation to the initial slope of the cell survival curve for tumours and bone marrow.

Authors:  T C Stephens; J H Peacock; W U Shipley; G G Steel
Journal:  Br J Cancer Suppl       Date:  1984

5.  Effects of dose rates on radiation-induced replenishment of intestinal stem cells determined by Lgr5 lineage tracing.

Authors:  Kensuke Otsuka; Toshiyasu Iwasaki
Journal:  J Radiat Res       Date:  2015-04-01       Impact factor: 2.724

6.  A model of photon cell killing based on the spatio-temporal clustering of DNA damage in higher order chromatin structures.

Authors:  Lisa Herr; Thomas Friedrich; Marco Durante; Michael Scholz
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

7.  Using state variables to model the response of tumour cells to radiation and heat: a novel multi-hit-repair approach.

Authors:  Stephan Scheidegger; Hans U Fuchs; Kathrin Zaugg; Stephan Bodis; Rudolf M Füchslin
Journal:  Comput Math Methods Med       Date:  2013-12-16       Impact factor: 2.238

8.  A Mechanistic DNA Repair and Survival Model (Medras): Applications to Intrinsic Radiosensitivity, Relative Biological Effectiveness and Dose-Rate.

Authors:  Stephen Joseph McMahon; Kevin M Prise
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.